American Journal of Clinical Dermatology

, Volume 18, Issue 4, pp 595–596 | Cite as

Author’s Reply to Cohen: Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment

  • Neelam A. Vashi
  • Mayra B. C. Maymone
  • Roopal V. Kundu
Letter to the Editor
  • 80 Downloads

Notes

Compliance with Ethical Standards

Funding

No sources of funding were used to assist in the preparation of this reply.

Conflict of interest

Neelam A. Vashi, Mayra B.C. Maymone, and Roopal V. Kundu have no conflicts of interest to declare.

References

  1. 1.
    Cohen PR. Comment on: facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017. doi: 10.1007/s40257-017-0303-z.
  2. 2.
    Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol. 2010;24:1312–6.CrossRefGoogle Scholar
  3. 3.
    Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Know SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17:E824.CrossRefGoogle Scholar
  6. 6.
    Na JI, Choi SY, Yang SH, Choi HR, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27(8):1035–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Neelam A. Vashi
    • 1
  • Mayra B. C. Maymone
    • 1
  • Roopal V. Kundu
    • 2
  1. 1.Department of DermatologyBoston University School of MedicineBostonUSA
  2. 2.Department of DermatologyNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations